Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation

NCT00249795 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00249795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00249795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2003
Completion date
August 31, 2009
Enrollment
9,016 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardiovascular disease